The alarming rise of GLP-1 drug overdoses among children: A growing concern
The popularity of GLP-1 drugs like Ozempic and Zepbound is on the rise, but so are the dangers. Recent reports reveal a disturbing trend: children are overdosing on these medications, and it's a serious issue that demands attention.
One harrowing case, as reported by WTHR, involved a 7-year-old girl named Jessa Milender. After accidentally injecting herself with her mother's GLP-1 injection, Jessa endured severe pain and constant vomiting. Her mother, Melissa, described the ordeal as a nightmare, with Jessa unable to walk or tolerate any touch on her stomach. Thankfully, Jessa recovered, but not without multiple hospitalizations.
GLP-1 drugs, such as semaglutide (Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro), have revolutionized obesity treatment, enabling significant weight loss. However, they also come with gastrointestinal side effects, especially when taken in excess or by those who shouldn't. Counterfeit medications, containing other drugs, have also been a concern.
In Jessa's case, she injected herself with her mother's Mounjaro, leading to a severe reaction. The poison control center warned of potential symptoms, but the family was unprepared for the intensity of Jessa's experience. Her condition worsened, with vomiting and abdominal pain, requiring hospitalization. Thankfully, she recovered, but the incident highlights the potential dangers.
The trend of GLP-1 overdoses is not isolated. Poison control calls related to these drugs have doubled in Indiana alone, and nationwide, there's a nearly 1500% increase in calls since 2019. Most cases involve accidental overdoses, but some involve children taking medications not intended for them. As GLP-1 therapy becomes more accessible and affordable, the risk of poisonings and overdoses may rise.
Experts emphasize the importance of careful dosing instructions, purchasing medications from reputable sources, and securing them from children. This lesson was learned the hard way by Melissa Milender, who now stores her GLP-1 medication in a lockbox.
The growing concern over GLP-1 drug overdoses among children is a critical issue that requires awareness and proactive measures to ensure the safety of these medications.
